All cancer treatments and medications that are used today, at one point, were clinical trials. Clinical trials can offer hope, particularly in a complex disease like cancer. But getting access to clinical trials can be difficult, especially if patients have to travel a long distance to a hospital that offers trials.
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112
Huntsman Cancer Institute Study Identifies Enhanced Impact of Treatment for Hereditary Cancer Patients
People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent findings published by researchers at Huntsman Cancer Institute at the University of Utah identified a promising prevention treatment for patients with FAP.
When she was first diagnosed with ovarian cancer, Dr. Jan Byrne didn't know of any survivors of the disease. "It's a devastating disease — a silent killer," she said. "A lot of people don't make it." Byrne's cancer was found in the early stages, however, and after six months of chemotherapy and three major surgeries at Huntsman Cancer Institute, she survived. It's been six years.
A study published today in Cell Systems highlights a new research method using the recently developed CRISPR technique. In short, CRISPR is a technology that allows researchers to cut out a section of DNA that causes a disease, like cancer, and then replace the section with normal, healthy genes.
Review indicates need to further explore relationship between fat and cancer. Adipose tissue, or fat, may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body, according to results of a systematic review published in Cancer Prevention Research, a journal of the American Association for Cancer Research
Mrs. Cándida Montilla de Medina, First Lady of the Dominican Republic, and her delegation visited Huntsman Cancer Institute (HCI) at the University of Utah yesterday, Thursday, August 10. During her visit, Mrs. Montilla de Medina toured HCI and met with physicians, researchers, Elder Ronald A. Rasband of The Church of Jesus Christ of Latter-day Saints, and members of the Huntsman family, including Jon M. Huntsman, Sr., to learn about HCI’s mission: to research cancer from its beginnings, develop new cancer treatments, and relieve the suffering of cancer patients.
Huntsman Cancer Institute (HCI) at the University of Utah is the first cancer center in the United States to use a new, state-of-the-art CT scanner that allows doctors to view higher quality, personalized images of a patient’s tumor. The scanner, called the Somatom Confidence 64 from Siemens, boasts numerous features that create more detailed images, giving physicians the ability to direct their therapy precisely where it’s needed.
Study Shows Shorter Course of Radiation May Be a Safe and Convenient Option for Breast Cancer Patients after Mastectomy
Research published in the Journal of Clinical Oncology demonstrates that a shorter course of radiation may be a good option for breast cancer patients who need radiation following mastectomy. The Phase II clinical trial examined the safety of treating women with a three-week course of radiation instead of the traditional six weeks.
Fox News reporter Abby Huntsman recently visited Salt Lake City to tour Huntsman Cancer Institute at the University of Utah and learn more about the cancer center's research impact.
Chemicals billionaire Jon Huntsman Sr. is one of the world’s great optimists. His mom died of cancer in her 50s, and he’s battled four different forms of the disease. His response was to launch the Huntsman Cancer Institute at the University of Utah in the 1990s. His audacious goal: to eradicate the most challenging forms of cancer in one generation. Then, says his son, Peter Huntsman, only half joking, with cancer research beat, he hopes they’ll be able to turn the cancer institute into a hotel.
State-of-the-Art Facility Opens to Expand Research in Cancers that Affect Children and Families and Accelerate the Development of New Treatments and Cancer Prevention Strategies
Mesa County, Colo.--- Grand Valley Oncology with the support of Huntsman Cancer Institute (HCI) at the University of Utah will offer a range of clinical trials for their patients. Physicians at Grand Junction Oncology will work closely with their counterparts at HCI to identify opportunities for patients in western Colorado to participate in clinical trials.
SALT LAKE CITY –Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults. Scientists have found up to 30 percent of adult ALL patients have what’s called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. (The fusion chromosome is much less common in children.) Adult ALL patients exposed to standard treatments often see high relapse rates, and treatment-related deaths remain high. But researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered new science, published this week in the journal Leukemia, that could provide better therapeutic options for patients.
Huntsman Cancer Institute at the University of Utah Selected to Join National Cancer Institute’s Systems Biology Consortium
SALT LAKE CITY – Huntsman Cancer Institute (HCI) and the College of Pharmacy at the University of Utah (U of U) have been awarded a $9.1 million, five-year grant from the National Cancer Institute (NCI) to serve as a Research Center in NCI’s Cancer Systems Biology Consortium (CSBC). HCI is one of nine research institutions nationwide to be selected as a Research Center in the CSBC.
CEO of Huntsman Cancer Institute Inducted Alongside President Obama to American Philosophical Society
SALT LAKE CITY – Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah, has been elected to highly distinguished membership in the American Philosophical Society (APS), joining a group of 32 inductees that includes former United States president Barack Obama.
Carson City, Nev. – Today, May 15, Carson Tahoe Cancer Center opened a new blood and bone marrow transplant care clinic with support from the Huntsman Cancer Institute (HCI) at the University of Utah. Under the collaboration, a Bone Marrow Transplant (BMT) physician and nurse from HCI will travel to Carson City once a month to treat patients both before and after they receive a transplant.
Huntsman Cancer Institute and Intermountain Healthcare Launch Joint Cancer Care Program for Adolescents and Young Adults
Huntsman Cancer Institute (HCI) at the University of Utah and Intermountain Cancer Centers announce a new collaboration today designed to meet the needs of adolescents and young adults (AYAs) between the ages of 15 and 39 who have been diagnosed with cancer. Each year over 1,000 adolescents and young adults in Utah are diagnosed with cancer, yet research has shown a number of gaps in their care.
Cognitive Stimulation, Social Interactions & Physical Activity Increase Lifespan in Mice with Colon Cancer
Living in a stimulating environment has a wide range of health benefits in humans and has even been shown to fight cancer in mice, but the underlying mechanisms have been unclear. A study published April 25 in Cell Reports reveals that cognitive stimulation, social interactions, and physical activity increase lifespan in mice with colon cancer by triggering the body's wound repair response.
University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.
More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics.
Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.
Public Affairs Manager
Public Relations Associate
After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.